Wolverine Asset Management’s Acceleron Pharma XLRN Stock Holding History

Wolverine Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,900	Closed	-$326K	–	2560
2021 Q3	$326K	Buy	1,900 +1,640	+631%	+$215K	﹤0.01%	1075
2021 Q2	$32K	Buy	+260	New	+$32.8K	﹤0.01%	1793
2020 Q4	–	Sell	-407	Closed	-$45K	–	1984
2020 Q3	$45K	Buy	407 +390	+2,294%	+$38.8K	﹤0.01%	1283
2020 Q2	$1K	Buy	+17	New	+$1.64K	﹤0.01%	1507

Wolverine Asset Management's XLRN Position: Q4 2021 in Review

Wolverine Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,900 shares — an estimated $326K sold.

Wolverine Asset Management first reported a position in XLRN in Q2 2020 and held it in 4 quarters. The position peaked at $326K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Wolverine Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Wolverine Asset Management sold 1,900 Acceleron Pharma shares in Q4 2021, an estimated $326K.
Wolverine Asset Management first reported a position in Acceleron Pharma in Q2 2020 and held it in 4 quarters.
Wolverine Asset Management's Acceleron Pharma position peaked at $326K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Wolverine Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.